The Lowdown on PCOS

by The Lowdown · May 29, 2021

Lady in PJS holding tummy
Professor Colin Duncan – one of the world’s leading experts on Polycystic Ovary Syndrome (PCOS) speaks with The Lowdown.

Polycystic Ovary Syndrome, also known as PCOS, is the most common endocrine and reproductive disorder affecting how ovaries work in approximately 7% of the female population worldwide. Whilst PCOS is notoriously difficult to diagnose, the disorder is characterised by three main symptoms – irregular periods, excess androgen, and ovarian cysts.

As PCOS affects such a large proportion of women, we invited Professor Colin Duncan – one of the world’s leading experts on this condition to come and talk with us.

Colin is Professor of Reproductive Medicine and Science at the University of Edinburgh, and has been studying how the ovary works in health and disease for years. He is currently working on better understanding of the pathways responsible for ‘normal’ fertility as well as examining the ways in which the environment before birth can program lifelong abnormalities of reproductive and metabolic function.

In this webinar, you’ll learn:

  • What is PCOS – and what it isn’t!
  • How to get diagnosed – and what symptoms you may experience
  • What causes it
  • What impact it has on our bodies and reasons why (periods, fertility, hair growth, weight gain etc)
  • What contraception and medicines help to manage the symptoms – including, does contraception ‘mask’ PCOS?
  • How to speak to your GP about PCOS – if you think they aren’t listening or may not know how to get you help.
  • Any new research or news that’s come out recently that’s exciting?
  • Resources – where are the best places to go for help?


  1. Burrows, L., Basha, M. and Goldstein, A., 2012. The Effects of Hormonal Contraceptives on Female Sexuality: A Review. The Journal of Sexual Medicine, 9(9), pp.2213-2223.

  2. Caruso, S., Agnello, C., Romano, M., Cianci, S., Lo Presti, L., Malandrino, C., & Cianci, A. (2011). Preliminary study on the effect of four‐phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life. Journal of Sexual Medicine, 8, 2841–2850. doi:10.1111/jsm.2011.8.issue-10

  3. Caruso S, Malandrino C, Cicero C, Ciancio F, Cariola M, and Cianci A. Quality of sexual life of women on oral contraceptive continued‐regimen: Pilot study. J Sex Med 2013;10:460-466.

  4. Davis, S., Moreau, M., Kroll, R., Bouchard, C., Panay, N., Gass, M., Braunstein, G., Hirschberg, A., Rodenberg, C., Pack, S., Koch, H., Moufarege, A. and Studd, J., 2009. Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen: A Phase III Research Study of Female Sexual Dysfunction in Women on Testosterone Patch Without Estrogen (APHRODITE). Obstetrical & Gynecological Survey, 64(3), pp.170-172.

  5. Davis, S. and Tran, J., 2001. Testosterone influences libido and well being in women. Trends in Endocrinology & Metabolism, 12(1), pp.33-37.

  6. Higgins, J. and Smith, N., 2016. The Sexual Acceptability of Contraception: Reviewing the Literature and Building a New Concept. The Journal of Sex Research, 53(4-5), pp.417-456.

  7. Nathorst-Böös, J., Flöter, A., Jarkander-Rolff, M., Carlström, K. and Schoultz, B., 2006. Treatment with percutanous testosterone gel in postmenopausal women with decreased libido – effects on sexuality and psychological general well-being. Maturitas, 53(1), pp.11-18.

  8. Pastor, Z., Holla, K. and Chmel, R., 2013. The influence of combined oral contraceptives on female sexual desire: A systematic review. The European Journal of Contraception & Reproductive Health Care, 18(1), pp.27-43.

  9. Rosenkrantz, D. and Mark, K., 2017. The Sociocultural Context of Sexually Diverse Women’s Sexual Desire. Sexuality & Culture, 22(1), pp.220-242.

  10. Sabatini, R. and Cagiano, R., 2006. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception, 74(3), pp.220-223.

  11. Schaffir, J., 2006. Hormonal Contraception and Sexual Desire: A Critical Review. Journal of Sex & Marital Therapy, 32(4), pp.305-314.

  12. Schaffir, J., Isley, M. and Woodward, M., 2010. Oral contraceptives vs injectable progestin in their effect on sexual behavior. American Journal of Obstetrics and Gynecology, 203(6), pp.545.e1-545.e5.

  13. Verywell Health. 2021. What Is Libido?. [online] Available at: <> [Accessed 14 October 2021].

  14. Wiebe, E., Brotto, L. and MacKay, J., 2011. Characteristics of Women Who Experience Mood and Sexual Side Effects With Use of Hormonal Contraception. Journal of Obstetrics and Gynaecology Canada, 33(12), pp.1234-1240.